Tag: Safety concerns of Alzheimer’s drug

news-23102024-165640

Risks of Landmark Alzheimer’s Drug Prevent Australian Release

The decision not to register the Alzheimer's drug, Lecanemab, in Australia by the Therapeutic Goods Administration (TGA) has sparked discussions around the world. The...